# Acceptability of Hepatitis B Vaccination in General Population

> **NCT01782794** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 2413 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT01782794
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 2413 (ACTUAL)
- **Last updated:** 2013-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01782794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01782794, "Acceptability of Hepatitis B Vaccination in General Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01782794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*